Position in TAK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,852,956
-$15,346,140 QoQ
Shares Held
2,049,467
-21.3% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 375 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Derivatives in TAK
reported options exposure · as of Dec 31, 2020CallValue
$273,000
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
2,049,467 | $32,852,956 |
All Filings in TAK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,852,956 | 2,049,467 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $48,199,096 | 2,602,543 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $66,939,562 | 4,293,750 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,118,144 | 281,294 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $833,255 | 56,036 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,739,873 | 122,354 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $4,921,213 | 354,299 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,067,436 | 214,957 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,144,335 | 267,895 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,510,639 | 287,119 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,763,622 | 410,414 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $3,404,236 | 237,726 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,593,938 | 190,311 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $273,000 | 15,000 | Call | Defined | 2021-02-16 | |
| 2020-09-30 | $267,600 | 15,000 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $268,950 | 15,000 | Call | Defined | 2020-08-14 | |
| 2020-03-31 | $3,037,214 | 200,080 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||